IV
119THCONGRESS
1
STSESSION H. RES. 305
Expressing support for the designation of the fourth Wednesday of February
as ‘‘Hypertrophic Cardiomyopathy Awareness Day’’.
IN THE HOUSE OF REPRESENTATIVES
APRIL8, 2025
Mr. L
AHOODsubmitted the following resolution; which was referred to the
Committee on Energy and Commerce
RESOLUTION
Expressing support for the designation of the fourth Wednes-
day of February as ‘‘Hypertrophic Cardiomyopathy
Awareness Day’’.
Whereas hypertrophic cardiomyopathy (‘‘HCM’’) is a chronic
cardiac disease involving thickening of the heart muscle
and can potentially lead to debilitating symptoms and se-
rious complications including heart failure, atrial fibrilla-
tion, stroke, and in rare cases sudden cardiac death;
Whereas HCM is the most common inheritable heart disease
and can affect anyone regardless of age, gender, or eth-
nicity with a reported prevalence ranging from 1 in 200
to 1 in 500 in the general population;
Whereas an estimated 700,000 to 1,650,000 people in the
United States have HCM, yet 85 percent of them may
remain undiagnosed;
VerDate Sep 11 2014 23:59 Apr 08, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6300 E:\BILLS\HR305.IH HR305
ssavage on LAPJG3WLY3PROD with BILLS 2
•HRES 305 IH
Whereas HCM shares symptoms with other common cardio-
vascular and pulmonary diseases, such as shortness of
breath, chest pain, fatigue, palpitations, and fainting,
making it difficult to distinguish HCM from these other
diseases;
Whereas, when untreated, all-cause mortality risk is 3 to 4
times higher in patients with HCM than that of the gen-
eral population;
Whereas knowing one’s medical history and any signs and
symptoms of HCM is an important first step in receiving
an accurate diagnosis of HCM;
Whereas a health care provider must conduct thorough
screening with cardiac health questions to help identify a
risk of cardiac disorders, both genetic and congenital;
Whereas a health care provider may conduct several tests, in-
cluding an echocardiogram, a cardiac MRI, or genetic
testing to confirm a family history of HCM, and must ex-
amine the heart to diagnose HCM;
Whereas, following a diagnosis of HCM, it is important for
patients to work with their health care provider to learn
more about their disease and understand different man-
agement options, including prescription medicines and
surgical treatment options that may help; and
Whereas ‘‘Hypertrophic Cardiomyopathy Awareness Day’’ is
expected to be observed in the United States for years to
come, providing hope and information for patients, care-
givers, and families around the country: Now, therefore,
be it
Resolved, That the House of Representatives— 1
VerDate Sep 11 2014 23:59 Apr 08, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\HR305.IH HR305
ssavage on LAPJG3WLY3PROD with BILLS 3
•HRES 305 IH
(1) supports the designation of ‘‘Hypertrophic 1
Cardiomyopathy Awareness Day’’; 2
(2) acknowledges the critical importance of hy-3
pertrophic cardiomyopathy awareness to improve 4
cardiovascular health; and 5
(3) recognizes the need to raise public aware-6
ness of the consequences of undiagnosed and un-7
treated hypertrophic cardiomyopathy and urges all 8
Americans to seek appropriate care. 9
Æ
VerDate Sep 11 2014 23:59 Apr 08, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6301 E:\BILLS\HR305.IH HR305
ssavage on LAPJG3WLY3PROD with BILLS